XBiotech (NASDAQ:XBIT) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research report report published on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. XBiotech Price Performance XBIT opened at $4.00 on Friday. The stock has a market cap of $121.75 million, a P/E ratio of -3.36 and […]
More Stories
US Company Puts Up Fight Against China’s Tariff Evasion
By Terri Wu Bradford Muller, vice president of a U.S. pipe company, thought that relief was finally on its way...
Virtual Reality Stocks To Watch Today – August 19th
Meta Platforms, Unity Software, Best Buy, GameStop, EPAM Systems, Ambarella, and Ambiq Micro are the seven Virtual Reality stocks to...
US and EU Unveil Trade Deal Details Covering Cars, Pharma, and Semiconductors
By Tom Ozimek The United States and European Union on Thursday issued a joint statement on Aug. 21 revealing details...
Israel Begins First Steps of Operation to Take Gaza City
By Guy Birchall The Israel Defense Forces (IDF) announced it had begun the first steps of an operation to take...
Money Wired to Mexico Hits a Decade Low as US Immigration Policies Take Hold
By Darlene McCormick Sanchez The Trump administration’s crackdown on illegal immigration is playing a role in the sharpest decline in...
Connor Clark & Lunn Investment Management Ltd. Takes Position in Palo Alto Networks, Inc. $PANW
Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Palo Alto Networks, Inc. (NASDAQ:PANW –...